7.23
price up icon1.12%   0.08
after-market Handel nachbörslich: 7.09 -0.14 -1.94%
loading
Schlusskurs vom Vortag:
$7.15
Offen:
$7.15
24-Stunden-Volumen:
1.95M
Relative Volume:
0.94
Marktkapitalisierung:
$880.45M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-29.07M
KGV:
-24.93
EPS:
-0.29
Netto-Cashflow:
$-31.85M
1W Leistung:
+0.28%
1M Leistung:
-3.47%
6M Leistung:
+62.84%
1J Leistung:
+145.08%
1-Tages-Spanne:
Value
$6.97
$7.305
1-Wochen-Bereich:
Value
$6.97
$7.52
52-Wochen-Spanne:
Value
$2.36
$8.78

Trevi Therapeutics Inc Stock (TRVI) Company Profile

Name
Firmenname
Trevi Therapeutics Inc
Name
Telefon
203-304-2499
Name
Adresse
195 CHURCH STREET, NEW HAVEN, CT
Name
Mitarbeiter
33
Name
Twitter
@TreviThera
Name
Nächster Verdiensttermin
2025-03-18
Name
Neueste SEC-Einreichungen
Name
TRVI's Discussions on Twitter

Vergleichen Sie TRVI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TRVI
Trevi Therapeutics Inc
7.23 885.32M 0 -29.07M -31.85M -0.29
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Trevi Therapeutics Inc Stock (TRVI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-21 Eingeleitet Morgan Stanley Overweight
2025-07-01 Eingeleitet Cantor Fitzgerald Overweight
2025-05-28 Eingeleitet H.C. Wainwright Buy
2025-03-10 Bestätigt Needham Buy
2025-03-10 Hochstufung Raymond James Outperform → Strong Buy
2024-12-12 Bestätigt H.C. Wainwright Buy
2024-09-09 Fortgesetzt Leerink Partners Outperform
2024-08-30 Eingeleitet H.C. Wainwright Buy
2024-08-30 Eingeleitet Raymond James Outperform
2024-06-13 Eingeleitet Rodman & Renshaw Buy
2023-04-12 Eingeleitet B. Riley Securities Buy
2022-11-22 Eingeleitet SVB Leerink Outperform
2019-06-03 Eingeleitet BMO Capital Markets Outperform
2019-06-03 Eingeleitet Needham Buy
2019-06-03 Eingeleitet SVB Leerink Outperform
2019-06-03 Eingeleitet Stifel Buy
Alle ansehen

Trevi Therapeutics Inc Aktie (TRVI) Neueste Nachrichten

pulisher
Sep 04, 2025

Tools to monitor Trevi Therapeutics Inc. recovery probabilityEntry Point & Free Technical Confirmation Trade Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Visualizing Trevi Therapeutics Inc. stock with heatmapsJuly 2025 PostEarnings & AI Driven Stock Price Forecasts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Will Trevi Therapeutics Inc. outperform the market in YEARJuly 2025 Movers & Verified Momentum Stock Ideas - khodrobank.com

Sep 04, 2025
pulisher
Sep 04, 2025

Can Trevi Therapeutics Inc. hit a new high this monthWeekly Market Report & Advanced Swing Trade Entry Plans - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Can Trevi Therapeutics Inc. reach resistance levels soonJuly 2025 Highlights & Weekly High Return Forecasts - khodrobank.com

Sep 04, 2025
pulisher
Sep 03, 2025

Why Trevi Therapeutics Inc. is moving today2025 Trade Ideas & Fast Entry Momentum Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will Trevi Therapeutics Inc. stock go up soonMarket Trend Summary & AI Forecast Swing Trade Picks - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Statistical indicators supporting Trevi Therapeutics Inc.’s strengthTrade Entry Report & AI Enhanced Market Trend Forecasts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can Trevi Therapeutics Inc. keep up with sector leadersJuly 2025 Fed Impact & Weekly Top Performers Watchlists - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Volume spikes in Trevi Therapeutics Inc. stock – what they meanTrade Volume Summary & Weekly Stock Breakout Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Pattern recognition hints at Trevi Therapeutics Inc. upside2025 Top Decliners & Weekly Return Optimization Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to monitor Trevi Therapeutics Inc. with trend dashboards2025 Analyst Calls & Daily Technical Forecast Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Trevi Therapeutics Inc.’s volatility index tracking explainedWeekly Investment Recap & Free Growth Oriented Trading Recommendations - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using AI based signals to follow Trevi Therapeutics Inc.Swing Trade & Technical Pattern Based Buy Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Trevi Therapeutics Inc. stock reversal real or fakeWeekly Market Outlook & Intraday High Probability Setup Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Trevi Therapeutics Inc. stock ready for a breakoutJuly 2025 Action & Fast Exit and Entry Strategy Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Has Trevi Therapeutics Inc. found a price floorGDP Growth & Weekly High Return Forecasts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Sentiment analysis tools applied to Trevi Therapeutics Inc.July 2025 Technicals & Real-Time Stock Movement Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Tools to assess Trevi Therapeutics Inc.’s risk profileTrade Exit Summary & AI Powered Buy/Sell Recommendations - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Will Trevi Therapeutics Inc. benefit from rate cutsMarket Sentiment Summary & AI Powered Market Entry Ideas - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

What is the target price for Trevi Therapeutics Inc. stockQuarterly Portfolio Review & AI Forecasted Stock Moves - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Volatility clustering patterns for Trevi Therapeutics Inc.Quarterly Profit Report & Community Verified Watchlist Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Real time breakdown of Trevi Therapeutics Inc. stock performanceWeekly Trend Report & Entry and Exit Point Strategies - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Trevi Therapeutics Inc. forming a bottoming baseWeekly Market Summary & Safe Capital Growth Tips - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

How does Trevi Therapeutics Inc. score in quality rankingsJuly 2025 Recap & Trade Opportunity Analysis Reports - khodrobank.com

Sep 02, 2025
pulisher
Sep 01, 2025

Full technical analysis of Trevi Therapeutics Inc. stockJuly 2025 PostEarnings & Weekly Watchlist for Hot Stocks - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Applying chart zones and confluence areas to Trevi Therapeutics Inc.Weekly Volume Report & Technical Analysis for Trade Confirmation - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Trevi Therapeutics Inc. stock trendline breakdown2025 Valuation Update & Growth-Oriented Investment Plans - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Signal strength of Trevi Therapeutics Inc. stock in tech scannersEarnings Risk Summary & Weekly Return Optimization Plans - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

RSI Reset May Fuel Rebound in Trevi Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com

Sep 01, 2025
pulisher
Aug 31, 2025

What Fibonacci levels say about Trevi Therapeutics Inc. rebound2025 Growth vs Value & Reliable Breakout Forecasts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Will Trevi Therapeutics Inc. rebound enough to break evenWeekly Risk Summary & AI Powered Market Trend Analysis - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

How institutional ownership impacts Trevi Therapeutics Inc. stock2025 Top Gainers & Capital Efficient Trade Techniques - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Trevi Therapeutics Inc. Stock Approaches Key Moving Average getLinesFromResByArray error: size == 0 - 더경남뉴스

Aug 31, 2025
pulisher
Aug 31, 2025

Does Trevi Therapeutics Inc. have high return on assets2025 Biggest Moves & Fast Moving Stock Trade Plans - 선데이타임즈

Aug 31, 2025

Finanzdaten der Trevi Therapeutics Inc-Aktie (TRVI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Trevi Therapeutics Inc-Aktie (TRVI) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
SCIASCIA THOMAS
Chief Scientific Officer
Mar 25 '25
Option Exercise
1.43
2,631
3,762
224,004
SCIASCIA THOMAS
Chief Scientific Officer
Mar 25 '25
Sale
6.60
2,631
17,365
221,373
GOOD JENNIFER L
President & CEO
Mar 21 '25
Option Exercise
1.43
5,263
7,526
218,576
GOOD JENNIFER L
President & CEO
Mar 21 '25
Sale
6.58
5,263
34,625
213,313
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):